Erfanian Hamid 4
4 · ENZO BIOCHEM INC · Filed Jun 17, 2022
Insider Transaction Report
Form 4
Erfanian Hamid
Chief Executive Officer
Transactions
- Purchase
Common Stock, $0.01 Par Value
2022-06-15$2.19/sh+4,600$10,074→ 274,600 total - Award
Stock Option (to acquire Common Stock)
2021-11-08+700,000→ 700,000 totalExercise: $3.39From: 2022-11-08Exp: 2026-11-08→ Common Stock (700,000 underlying)
Footnotes (1)
- [F1]The Reporting Person was granted 700,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022.